🧠 Rapid Cycling Bipolar Disorder Simulator

Counting Episodes — Establishing the Annual Baseline

Placeholder: baseline count anchors all downstream cycling calculations.

• ≥4: Episodes/year (DSM cut) (Placeholder short caption)
• 1–2/yr: Typical bipolar I rate (Placeholder short caption)
• ~15–20%: Rapid cyclers, all bipolar (Placeholder short caption)
• ~70%: Female predominance (Placeholder short caption)

Defining the episode-counting window

Placeholder: episodes tallied over trailing twelve months per DSM criteria. Placeholder: mania, hypomania, depression, and mixed states all count. Placeholder: distinct episodes require partial remission or polarity switch.

Antidepressants as a Cycle-Acceleration Trigger

Placeholder: antidepressant monotherapy can shorten inter-episode intervals.

• ~20–40%: Switch risk (unopposed AD) (Placeholder short caption)
• Common: Cycle acceleration cases (Placeholder short caption)
• Taper: Recommended action (Placeholder short caption)
• Mood stabilizer: Preferred alternative (Placeholder short caption)

Mechanism of antidepressant-induced cycling

Placeholder: monoaminergic activation destabilizes circadian mood regulation. Placeholder: risk rises with tricyclics more than modern agents. Placeholder: discontinuation often part of stabilization protocol.

Thyroid Axis Dysfunction and Mood Instability

Placeholder: hypothyroidism is strongly linked to rapid cycling presentations.

• ~30%: Rapid cyclers with hypothyroidism (Placeholder short caption)
• ~20%: Lithium-induced hypothyroidism (Placeholder short caption)
• TSH q6-12mo: Recommended monitoring (Placeholder short caption)
• Often: Correction improves cycling (Placeholder short caption)

Thyroid-mood axis interaction

Placeholder: subclinical and overt hypothyroidism both worsen cycling. Placeholder: lithium therapy itself can induce thyroid dysfunction. Placeholder: thyroid correction is a first-line stabilization step.

Crossing the ≥4 Episodes/Year Threshold

Placeholder: threshold crossing reclassifies course as rapid cycling specifier.

• ≥4/yr: DSM-5 threshold (Placeholder short caption)
• <24–48h: Ultradian cycling (Placeholder short caption)
• Worse: Prognosis vs standard course (Placeholder short caption)
• Higher: Treatment resistance (Placeholder short caption)

Clinical significance of the threshold

Placeholder: threshold triggers specifier coding and treatment escalation. Placeholder: combined triggers push patients well past the cutoff. Placeholder: early recognition limits long-term functional decline.

Flattening the Curve — Stabilization Strategies

Placeholder: combined pharmacologic and lifestyle strategies dampen oscillation.

• Lithium/valproate: First-line agents (Placeholder short caption)
• Avoid/taper: Antidepressant policy (Placeholder short caption)
• Levothyroxine: Thyroid correction (Placeholder short caption)
• Euthymia: Remission target (Placeholder short caption)

Multimodal stabilization protocol

Placeholder: mood stabilizer optimization forms the treatment backbone. Placeholder: removing antidepressants and correcting thyroid reduce triggers. Placeholder: sleep and rhythm regulation support long-term remission.

Placeholder: combined trigger removal plus stabilizer flattens the cycle.